Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaroslav Tsybovsky

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|June 30, 2020
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen DevelopmentRebecca J Loomis, Guillaume B E Stewart-Jones, Yaroslav Tsybovsky, et al.
Nature|April 1, 2021
Structural basis of malaria RIFIN binding by LILRB1-containing antibodiesYiwei Chen, Kai Xu, Luca Piccoli, et al.
Nature Communications|March 20, 2021
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodiesAdrian Creanga, Rebecca A Gillespie, Brian E Fisher, et al.
Journal of Virology|December 16, 2025
Demonstration of <i>in vivo</i> efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodiesChristina L Gardner, Sergei Pletnev, Jinny L Liu, et al.
NPJ Vaccines|December 15, 2020
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopesRaffaello Verardi, Lisa C Lindesmith, Yaroslav Tsybovsky, et al.
Plos Pathogens|October 22, 2021
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimensEmma T Crooks, Francisco Almanza, Alessio D'Addabbo, et al.
Vaccine|May 22, 2021
A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluationKrishana Gulla, Nicole Cibelli, Jonathan W Cooper, et al.
Scientific Reports|February 24, 2024
Mosaic quadrivalent influenza vaccine single nanoparticle characterizationRong Sylvie Yang, Maria Traver, Nathan Barefoot, et al.
Nature Communications|July 10, 2021
Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINsKai Xu, Yiran Wang, Chen-Hsiang Shen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Antigen spacing on protein nanoparticles influences antibody responses to vaccinationDaniel Ellis, Annie Dosey, Seyhan Boyoglu-Barnum, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|June 30, 2020
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen DevelopmentRebecca J Loomis, Guillaume B E Stewart-Jones, Yaroslav Tsybovsky, et al.
Nature|April 1, 2021
Structural basis of malaria RIFIN binding by LILRB1-containing antibodiesYiwei Chen, Kai Xu, Luca Piccoli, et al.
Nature Communications|March 20, 2021
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodiesAdrian Creanga, Rebecca A Gillespie, Brian E Fisher, et al.
Journal of Virology|December 16, 2025
Demonstration of <i>in vivo</i> efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodiesChristina L Gardner, Sergei Pletnev, Jinny L Liu, et al.
NPJ Vaccines|December 15, 2020
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopesRaffaello Verardi, Lisa C Lindesmith, Yaroslav Tsybovsky, et al.
Plos Pathogens|October 22, 2021
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimensEmma T Crooks, Francisco Almanza, Alessio D'Addabbo, et al.
Vaccine|May 22, 2021
A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluationKrishana Gulla, Nicole Cibelli, Jonathan W Cooper, et al.
Scientific Reports|February 24, 2024
Mosaic quadrivalent influenza vaccine single nanoparticle characterizationRong Sylvie Yang, Maria Traver, Nathan Barefoot, et al.
Nature Communications|July 10, 2021
Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINsKai Xu, Yiran Wang, Chen-Hsiang Shen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Antigen spacing on protein nanoparticles influences antibody responses to vaccinationDaniel Ellis, Annie Dosey, Seyhan Boyoglu-Barnum, et al.
Pageof 14